These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24681627)

  • 21. Phosphatidylinositol 4,5-bisphosphate (PIP
    Tembo M; Wozniak KL; Bainbridge RE; Carlson AE
    J Biol Chem; 2019 Aug; 294(33):12556-12564. PubMed ID: 31266809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical and functional interaction sites in cytoplasmic domains of KCNQ1 and KCNE1 channel subunits.
    Chen J; Liu Z; Creagh J; Zheng R; McDonald TV
    Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H212-H222. PubMed ID: 31834838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.
    Shamgar L; Ma L; Schmitt N; Haitin Y; Peretz A; Wiener R; Hirsch J; Pongs O; Attali B
    Circ Res; 2006 Apr; 98(8):1055-63. PubMed ID: 16556865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction.
    Biliczki P; Girmatsion Z; Brandes RP; Harenkamp S; Pitard B; Charpentier F; Hébert TE; Hohnloser SH; Baró I; Nattel S; Ehrlich JR
    Heart Rhythm; 2009 Dec; 6(12):1792-801. PubMed ID: 19959132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
    Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
    Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero.
    Hong K; Piper DR; Diaz-Valdecantos A; Brugada J; Oliva A; Burashnikov E; Santos-de-Soto J; Grueso-Montero J; Diaz-Enfante E; Brugada P; Sachse F; Sanguinetti MC; Brugada R
    Cardiovasc Res; 2005 Dec; 68(3):433-40. PubMed ID: 16109388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ca
    Tobelaim WS; Dvir M; Lebel G; Cui M; Buki T; Peretz A; Marom M; Haitin Y; Logothetis DE; Hirsch JA; Attali B
    Channels (Austin); 2017 Nov; 11(6):686-695. PubMed ID: 28976808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hERG mutation E1039X produced a synergistic lesion on I
    Wu J; Mizusawa Y; Ohno S; Ding WG; Higaki T; Wang Q; Kohjitani H; Makiyama T; Itoh H; Toyoda F; James AF; Hancox JC; Matsuura H; Horie M
    Sci Rep; 2018 Feb; 8(1):3129. PubMed ID: 29449639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A590T mutation in KCNQ1 C-terminal helix D decreases IKs channel trafficking and function but not Yotiao interaction.
    Kinoshita K; Komatsu T; Nishide K; Hata Y; Hisajima N; Takahashi H; Kimoto K; Aonuma K; Tsushima E; Tabata T; Yoshida T; Mori H; Nishida K; Yamaguchi Y; Ichida F; Fukurotani K; Inoue H; Nishida N
    J Mol Cell Cardiol; 2014 Jul; 72():273-80. PubMed ID: 24713462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatidylinositol-4,5-bisphosphate (PIP(2)) stabilizes the open pore conformation of the Kv11.1 (hERG) channel.
    Rodriguez N; Amarouch MY; Montnach J; Piron J; Labro AJ; Charpentier F; Mérot J; Baró I; Loussouarn G
    Biophys J; 2010 Aug; 99(4):1110-8. PubMed ID: 20712994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A molecular mechanism for adrenergic-induced long QT syndrome.
    Wu J; Naiki N; Ding WG; Ohno S; Kato K; Zang WJ; Delisle BP; Matsuura H; Horie M
    J Am Coll Cardiol; 2014 Mar; 63(8):819-27. PubMed ID: 24184248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual effect of phosphatidylinositol (4,5)-bisphosphate PIP(2) on Shaker K(+) [corrected] channels.
    Abderemane-Ali F; Es-Salah-Lamoureux Z; Delemotte L; Kasimova MA; Labro AJ; Snyders DJ; Fedida D; Tarek M; Baró I; Loussouarn G
    J Biol Chem; 2012 Oct; 287(43):36158-67. PubMed ID: 22932893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mutation in KCNQ1 associated with a potent dominant negative effect as the basis for the LQT1 form of the long QT syndrome.
    Aizawa Y; Ueda K; Scornik F; Cordeiro JM; Wu Y; Desai M; Guerchicoff A; Nagata Y; Iesaka Y; Kimura A; Hiraoka M; Antzelevitch C
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):972-7. PubMed ID: 17655673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome.
    Sun J; MacKinnon R
    Cell; 2017 Jun; 169(6):1042-1050.e9. PubMed ID: 28575668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The membrane protein KCNQ1 potassium ion channel: Functional diversity and current structural insights.
    Dixit G; Dabney-Smith C; Lorigan GA
    Biochim Biophys Acta Biomembr; 2020 May; 1862(5):183148. PubMed ID: 31825788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
    El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
    J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk.
    Chouabe C; Neyroud N; Richard P; Denjoy I; Hainque B; Romey G; Drici MD; Guicheney P; Barhanin J
    Cardiovasc Res; 2000 Mar; 45(4):971-80. PubMed ID: 10728423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional suppression of Kcnq1 leads to early sodium channel remodelling and cardiac conduction system dysmorphogenesis.
    de la Rosa AJ; Domínguez JN; Sedmera D; Sankova B; Hove-Madsen L; Franco D; Aránega AE
    Cardiovasc Res; 2013 Jun; 98(3):504-14. PubMed ID: 23542581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A trafficking-deficient KCNQ1 mutation, T587M, causes a severe phenotype of long QT syndrome by interfering with intracellular hERG transport.
    Wu J; Sakaguchi T; Takenaka K; Toyoda F; Tsuji K; Matsuura H; Horie M
    J Cardiol; 2019 May; 73(5):343-350. PubMed ID: 30591322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional effects of a KCNQ1 mutation associated with the long QT syndrome.
    Boulet IR; Raes AL; Ottschytsch N; Snyders DJ
    Cardiovasc Res; 2006 Jun; 70(3):466-74. PubMed ID: 16564513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.